Document is current
Any future updates will be listed below
-
Authors
Møller, Janne https://orcid.org/0000-0003-1839-3669
Hilberg, Ole https://orcid.org/0000-0002-4238-6963
Bendstrup, Elisabeth
-
Funding
Funding for this research was provided by:
Spydspids Foundation
Frölich Foundation
Jens Ove Jacobsens Foundation
- License Information
-
More Information
Article History
Received: 15 December 2022
Accepted: 25 January 2023
First Online: 11 February 2023
Declarations
:
: Janne Møller (JM) received honoraria for presentations from Hoffman la Roche and Novartis outside this work. Ole Hilberg (OH) received honoraria for presentations from Chiesi, GSK, and AstraZeneca, support for travel and attending meetings from Sanofi, and participated in Advisory Boards with ALK, MSD, and TEVA. Elisabeth Bendstrup (EB) received honoraria for presentations from Boehringer Ingelheim, Hoffman la Roche, and AstraZeneca and support for travel and attending meetings from Boehringer Ingelheim.
: This study protocol was reviewed and approved by Central Denmark Region Data Protection agency [case approval number: 1-16-02-90-19]. According to Danish legislation, permission from the Scientific Ethical Committee was not required. Written informed consent was obtained from all participants.
: Informed consent was obtained from all individual participants included in the study.
